// App-Quantinova.ai

OP0256 (2018) : Hydroxychloroquine reduces risk of incident diabetes mellitus in primary sjÖgren syndrome patients: a propensity score matched population-based cohort study

Researchers

Presenter

  • W.-S. Chen

Principal Investigators

  • C.-Y. Tsai

  • C.-C. chang

Medical Centers

  • Rheumatology, Taipei Veterans General Hospital

  • Rheumatology, Taipei medical Hospital, Taipei, Taiwan, Province of China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetes

  • Sjogren's syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved